A prospective study of the usefulness of liquid biopsy as biomarker during diagnosis and treatment for the ovarian cancer

A prospective study of the usefulness of liquid biopsy as biomarker during diagnosis and treatment for the ovarian cancer - A prospective study of the usefulness of liquid biopsy as biomarker for the ovarian cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027119

Enrollment

Registered

2017-05-08

Start date

2017-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The patients with ovarian cancer who are planned to treat according our protocol.

Exclusion criteria

Exclusion criteria: The patients are followed our protocol.

Design outcomes

Primary

Measure	Time frame
Concordance rate of liquid biopsy and gene mutation in tumor tissue specimen	—

Secondary

Measure	Time frame
PFS by liquid biopsy OS by liquid biopsy	—

Countries

Japan

Contacts

Public ContactNaoyuki Iwahashi

Wakayama medical university Obstetrics and gynecology

naoyuki@wakayama-med.ac.jp073-441-0631

Outcome results